Ishibe M, Ishibe Y, Ishibashi T, Nojima T, Rosier R N, Puzas J E, Kaneda K
Department of Orthopaedics, Hokkaido University, School of Medicine, Sapporo, Japan.
Arch Orthop Trauma Surg. 1994;113(2):106-9. doi: 10.1007/BF00572916.
We tried to identify estrogen receptors (ERs) in human giant cell tumors of bone. Samples from eight patients were used for biochemical and immunohistochemical studies using [125I]17 beta-estradiol and monoclonal antibody against the human ER. Estradiol binding sites were detected in seven cases out of eight. The dissociation constant of the higher affinity binding site was 0.5 nM. Nonlabeled 17 beta-estradiol and synthetic estrogen, diethyl-stilbestrol, inhibited the binding of labeled 17 beta-estradiol to the tumor cytosol, while dexamethasone did not inhibit the binding. Using a monoclonal antibody. Western blotting identified bands of M(r) 68,000 and 59,000. No ERs were observed in any case examined immunohistochemically. These results suggest that human giant cell tumors of bone have a low level of ERs that cannot be detected immunohistochemically.
我们试图鉴定人骨巨细胞瘤中的雌激素受体(ERs)。使用来自8名患者的样本进行生物化学和免疫组织化学研究,采用[125I]17β-雌二醇和抗人ER单克隆抗体。在8例中的7例检测到雌二醇结合位点。高亲和力结合位点的解离常数为0.5 nM。未标记的17β-雌二醇和合成雌激素己烯雌酚抑制标记的17β-雌二醇与肿瘤细胞溶质的结合,而地塞米松不抑制这种结合。使用单克隆抗体,蛋白质印迹法鉴定出分子量为68,000和59,000的条带。在任何免疫组织化学检查的病例中均未观察到ERs。这些结果表明人骨巨细胞瘤具有低水平的ERs,无法通过免疫组织化学检测到。